Publications | Lund University Publications

91 – 97 of 97

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+med-ava+or+(documenttype+any+%22bookEditor+conferenceEditor%22+and+editor+exact+med-ava)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
…
7
8
9
10
next »

2008
Mark Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Lund, Soren S ; Tarnow, Lise ; Frandsen, Merete ; Smidt, Ulla M. ; Pedersen, Oluf ; Parving, Hans-Henrik and Vaag, Allan ^LU (2008) In European Journal of Endocrinology 158(1). p.35-46
- Contribution to journal › Article
Mark Sex and muscle structural lipids in obese subjects - an impact on insulin action?
Haugaard, S B ; Vaag, Allan ^LU ; Hoy, C-E and Madsbad, S (2008) In European Journal of Clinical Investigation 38(7). p.494-501
- Contribution to journal › Article
Mark Sustained postprandial decrease in plasma levels of LDL cholesterol in patients with type-2 diabetes mellitus
Lund, S. S. ; Petersen, M. ; Frandsen, M. ; Smidt, U. M. ; Parving, H. -H. ; Vaag, Allan ^LU and Jensen, T. (2008) In Scandinavian Journal of Clinical & Laboratory Investigation 68(7). p.628-640
- Contribution to journal › Article
Mark Impact of metformin versus repaglinide on non-glycaemic cardiovascular risk markers related to inflammation and endothelial dysfunction in non-obese patients with type 2 diabetes
Lund, Soren S ; Tarnow, Lisc ; Stehouwer, Coen D A ; Schalkwijk, Casper G ; Teerlink, Tom ; Gram, Jorgen ; Winther, Kaj ; Frandsen, Merete ; Smidt, Ulla M and Pedersen, Oluf , et al. (2008) In European Journal of Endocrinology 158(5). p.631-641
- Contribution to journal › Article
2007
Mark Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
Lund, S. S. ; Tarnow, L. ; Stehouwer, C. D. A. ; Schalkwijk, C. G. ; Frandsen, M. ; Smidt, U. M. ; Pedersen, O. ; Parving, H. -H. and Vaag, Allan ^LU (2007) In Diabetes, Obesity and Metabolism 9(3). p.394-407
- Contribution to journal › Article
Mark Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?
Vaag, Allan ^LU and Lund, Søren S. (2007) In Applied Physiology, Nutrition and Metabolism 32(5). p.912-920
- Contribution to journal › Article
Mark Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, Claus M. ; Faulenbach, Mirjam ; Vaag, Allan ^LU ; Volund, Aage ; Ehses, Jan A. ; Seifert, Burkhardt ; Mandrup-Poulsen, Thomas and Donath, Marc Y. (2007) In New England Journal of Medicine 356(15). p.1517-1526
- Contribution to journal › Article

« previous
1
2
…
7
8
9
10
next »

your query:: Remove author: Vaag, Allan (LU)